Navigation Links
Amgen to Present at the Goldman Sachs Global Healthcare Conference
Date:6/8/2009

THOUSAND OAKS, Calif., June 8 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) will present at the Goldman Sachs Global Healthcare Conference on Wednesday, June 10, 2009 at the Grand Hyatt, New York City, N.Y., beginning at 9:00 a.m. Eastern Time. Roger M. Perlmutter, Amgen's Executive Vice President of Research & Development, will present. Live audio of the presentation will be available over the Internet and can be accessed from Amgen's Web site, www.amgen.com, under Investors.

Information regarding presentation time, webcast availability, and webcast links are available on Amgen's Investor Relations Events Calendar.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

    CONTACT: Amgen, Thousand Oaks
    David Polk, 805-447-4613 (media)
    John Shutter, 805-447-1060 (investors)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Loyola fellow receives Amgen grant to study treatments for older leukemia patients
2. Amgens Denosumab and Eli Lillys Forteo/Forsteo Will Drive Robust Annual Growth in the Osteoporosis Drug Market From 2013 to 2018
3. Amgen Highlights Data to Be Presented at ASCO
4. Amgen to Present at the Deutsche Bank 34th Annual Healthcare Conference
5. Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
6. Amgens First Quarter 2009 Adjusted Earnings Per Share Decreased 4 Percent to $1.08
7. Amgen Announces Webcast of 2009 First Quarter Financial Results
8. Amgen to Present at the Barclays Capital Global Healthcare Conference
9. OmniPod(R) Insulin Management System Lets Team Type 1 Members Focus on Competing at Amgen Tour of California
10. InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
11. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... March 30, 2015 Dr. Jeff Farmer now ... , The mini implant is placed into the bone, usually ... is fitted and snapped into place. For those having trouble ... implants could be the solution. Thousands of patients around the ... without any adhesives. It is all made possible by mini ...
(Date:3/30/2015)... Columbus, OH (PRWEB) March 30, 2015 ... in product liability lawsuits, notes that the number of ... federal multidistrict litigation underway in U.S. District Court, District ... established in December 2014. "According to an update released ... on March 16th, at least 493 Syngenta lawsuits are ...
(Date:3/30/2015)... New York (PRWEB) March 30, 2015 ... been filed in California Superior Court on behalf of ... heart birth defect after his mother was prescribed the ... to the March 6th filing in Alameda Superior Court, ... nausea and vomiting that she experienced in the early ...
(Date:3/30/2015)... 30, 2015 On March 11, 2015, Elle ... Away Fat,” details six new treatment options for dealing with ... one is a topical product. The other three technologies use ... Liposonix ) or freezing cold ( CoolSculpting ) to kill ... now available to us to permanently remove unwanted fat," says ...
(Date:3/30/2015)... In a recent report published by ... is championing effective drug and alcohol treatment for victims ... recover funds to stabilize the addiction treatment programs, and ... drug and alcohol addiction. Harbor Village Detox is extending ... use disorders in New Jersey, in hopes to help ...
Breaking Medicine News(10 mins):Health News:Dr. Jeffrey Farmer A Murfreesboro Dentist Announces New High Tech Dentistry 2Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 2Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 4Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3
... services rendered to Scotland children, could soon come to an ... out by ministers. // Dental practices in Scotland yield a ... number of registered NHS patients. ,There exists a ... such extra payments, says the British Dental Association (BDA). This ...
... study and found that the rates have increased among those who ... getting their children immunized with the three-in-one MMR jab in Scotland. ... level of 95% by the age of two. But there was ... due to the vaccines association with the childhood autism disease. ...
... newly developed bird flu vaccine would soon be launched ... national pharmaceutical agency //. The Prime Minister, Ferenc Gyurcsany, ... the much dreaded bird flu, last year. Vaccine trials ... results. The bird flu vaccine is claimed to confer ...
... of researchers from Warwick Medical School found that premature babies ... ,The study included 120,000 children born between 1983 and ... low birth weight and were born premature are more often ... include those that were born before 34 weeks. The findings ...
... patients at the Siteman Cancer Center are a part ... the School of Medicine's Medical Photography, Illustration and Computer ... Matters," invites patients and their families to paint a ... than 400 tiles have been painted in this manner. ...
... a local clinic now you can take a simple test ... ,Chlamydia is the most common sexually transmitted infection in the ... on to others without knowing. However, complications may occur if ... in both men and women., ,The Preventx kits are ...
Cached Medicine News:Health News:Children In Scotland Denied Access To Dental Care 2Health News:Home Chlamydia Test 2
(Date:3/30/2015)... , March 30, 2015 ... nurse call systems," announced the high level interface ... the ClinicAll infotainment systems. The partnership ... patient entertainment terminals; this allows patients to choose ... their need and acuity. The advanced functionality of ...
(Date:3/30/2015)... March 30, 2015 DURECT Corporation (Nasdaq: ... initiated a multi-dose Phase 1 clinical trial of ... in DURECT,s Epigenomic Regulator Program.  DUR-928 is an ... have broad applicability in metabolic diseases such as ... (NASH).  It may also play an important role ...
(Date:3/30/2015)... Calif. , March 30, 2015  BioPharmX ... on the development of novel drug delivery products ... underserved markets, today announced the appointment of ... retail industry veteran, to its board of directors.  ... it continues to expand its national roll-out of ...
Breaking Medicine Technology:NiQ Health Announces CarePlus(TM) Integration with ClinicAll 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 2BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 3
... Aug. 20, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: ... leading China-based biotechnology company focused on researching, developing, ... the annual general meeting of shareholders of 3SBio ... at 10:00 a.m., Shenyang time, at our executive ...
... As Medicare expands a controversial "competitive" bidding program for home ... Congress have gone on record to oppose that program citing ... and impact on local jobs. "There,s a reason ... 244 economists and auction experts , and 145 members ...
Cached Medicine Technology:3SBio Inc. to Hold 2011 Annual General Meeting on September 20, 2011 2Myths and Realities About Medicare's Competitive Bidding Program for Home Medical Equipment and Services 2Myths and Realities About Medicare's Competitive Bidding Program for Home Medical Equipment and Services 3Myths and Realities About Medicare's Competitive Bidding Program for Home Medical Equipment and Services 4Myths and Realities About Medicare's Competitive Bidding Program for Home Medical Equipment and Services 5
MagaCell-Streptavidin is a streptavidin coupled to magnetizable cellulose/iron oxide particles...
Streptavidin A-Beads are polydisperse 1.8 m paramagnetic particles covalently coupled with streptavidin. The paramagnetic particles remain in solution over extended periods of time. Mixing is require...
QuantumPlex is a bead kit for multiple analyte-detection research applications in flow cytometry. The beads may be analyzed with any standard cytometer and do not require the use of specialized softw...
... OptiMAL® assay is a sensitive, ... that permits the detection of ... malaria; and can distinguish between ... P. vivax . In ...
Medicine Products: